Patents expiring in 2045

US 12383512

Cannabidiol-type cannabinoid compound

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12383545

TREATMENT OF MIGRAINE

ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12383516

Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

Amphastar Pharmaceuticals, Inc. · Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12390419

Formulations of (R)-2-amino-3-phenylpropyl carbamate

AXSOME MALTA LTD. · Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12390453

Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

ARCUTIS BIOTHERAPEUTICS, INC. · Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12398087

Methods of making bempedoic acid and compositions of the same

Esperion Therapeutics, Inc. · Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12396963

Cannabidiol-type cannabinoid compound

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12403090

Oral film compositions and dosage forms having precise active dissolution profiles

Aquestive Therapeutics, Inc. · Granted Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12404227

Methods of making bempedoic acid and compositions of the same

Esperion Therapeutics, Inc. · Granted Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12410184

Crystalline forms of a menin inhibitor

Kura Oncology, Inc. · Granted Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12414942

Compositions, methods, and systems for treating presbyopia

LENZ THERAPEUTICS OPERATIONS, INC. · Granted Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 12419895

Methods for treating subjects with Prader-Willi syndrome

ESSENTIALIS, INC. · Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2025295738

Long-Acting Growth Hormone Dosage Forms With Superior Efficacy to Daily Somatropin

ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S [DK] · Granted Thu Sep 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Sep 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2025221754

UPADACITINIB DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE L'ARTÉRITE À CELLULES GÉANTES

ABBVIE INC [US] · Granted Thu Oct 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)